.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
01.04.2022
Podcast: Understanding Today's Lipid-based Formulation Landscape
As a drug delivery system, lipid-based formulations provide improved stability of an API and allow for safe, efficient delivery...
News & Insights
Emergent CDMO News, Insights & Events
When a company develops, manufactures and delivers vaccines and therapeutics that take on the most serious global health threats, it’s not surprising to see their name in the headlines. And we are honored that for more than 20 years, Emergent has been one of those names. Included below are prominent news and feature stories that profile a range of our accomplishments through the years as well as advancements we’ve made in the technologies, processes and expertise needed to serve as a premier CDMO.
12.11.2021
Ondemand Webinar: HIGH-SPEED MANUFACTURING FOR YOUR VIRAL VACCINE OR THERAPEUTIC
Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...
11.19.2021
Finding the Right CDMO Partner for Tech Transfer
Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...
09.14.2021
Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B
- Total baseline value for Emergent is approximately $90 million USD, further expanding the collaboration between the companies,...
08.30.2021
Utilizing Expertise & Experience for Successful Downstream Processing
Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation,...
08.19.2021
Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape
Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...